Inhibitor Therapeutics, Inc. Exclusive License with Johns Hopkins University ...Middle East

PR Newswire - News
Inhibitor Therapeutics, Inc. Exclusive License with Johns Hopkins University
A critical milestone completed on the mission path of commercializing Itraconazole in numerous oncology indications. TAMPA, Fla., Dec. 13, 2023 /PRNewswire/ -- Inhibitor Therapeutics, Inc. ("Inhibitor") (OTCQB: INTI) has entered into an exclusive, worldwide licensing agreement (the...

Hence then, the article about inhibitor therapeutics inc exclusive license with johns hopkins university was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Inhibitor Therapeutics, Inc. Exclusive License with Johns Hopkins University )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News